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Intracellular Fe plays a key role in redox active energy and electron
transfer. We sought to understand how Fe levels impact the retina,
given that retinal pigment epithelial (RPE) cells are also challenged by
accumulations of vitamin A aldehyde adducts (bisretinoid lipofuscin)
that photogenerate reactive oxygen species and photodecompose
into damaging aldehyde- and dicarbonyl-bearing species. In mice
treated with the Fe chelator deferiprone (DFP), intracellular Fe levels,
as reflected in transferrin receptor mRNA expression, were reduced.
DFP-treated albino Abca4−/− and agouti wild-type mice exhibited
elevated bisretinoid levels as measured by high-performance liquid
chromatography or noninvasively by quantitative fundus autofluor-
escence. Thinning of the outer nuclear layer, a parameter indicative
of the loss of photoreceptor cell viability, was also reduced in DFP-
treated albino Abca4−/−. In contrast to the effects of the Fe chelator,
mice burdened with increased intracellular Fe in RPE due to defi-
ciency in the Fe export proteins hephaestin and ceruloplasmin, pre-
sented with reduced bisretinoid levels. These findings indicate that
intracellular Fe promotes bisretinoid oxidation and degradation. This
interpretation was supported by experiments showing that DFP de-
creased the oxidative/degradation of the bisretinoid A2E in the pres-
ence of light and reduced cell death in cell-based experiments.
Moreover, light-independent oxidation and degradation of A2E by
Fenton chemistry products were evidenced by the consumption of
A2E, release of dicarbonyls, and generation of oxidized A2E species
in cell-free assays.
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While Fe is required for many metabolic processes, it is alsoa redox-active metal capable of causing molecular and
cellular dysfunction by catalyzing the formation of hydroxyl free
radical (OH•) via the Fenton reaction (1). Accordingly, several
mechanisms operate to regulate Fe import, storage, and export
to prevent Fe overload or deficiency (1). Most nonheme Fe is
bound to transferrin in the circulation. For access to the retina,
Fe-laden transferrin binds to the transferrin receptor on the
basolateral surface of retinal pigment epithelial (RPE) cells and
the apical surface of retinal vascular endothelial cells. Both of
these surfaces face the blood supply. Within RPE cells, Fe dis-
sociates from transferrin to enter a cytosolic pool of labile Fe
that can be utilized, stored, or exported. Intracellular Fe can be
stored in ferritin, a multisubunit protein consisting of heavy (H)
and light (L) chains. Ferroportin exports ferrous (Fe2+) Fe that is
not utilized or stored. Since only ferric (Fe3+) Fe can be accepted
by transferrin in the circulation, ferroportin coordinates with fer-
roxidases such as ceruloplasmin (Cp), or hephaestin (Heph)
within the plasma membrane, to oxidize Fe from the ferrous Fe2+
(four unpaired electrons) to ferric Fe3+ (five unpaired electrons)
form. This conversion is also protective since oxidation of Fe from
Fe2+ to Fe3+ prevents Fe2+-mediated oxidative damage by means
of hydroxyl free radical generation (Fenton reaction).
Fe excess or dysregulation in the eye is toxic to photoreceptors
and RPE when introduced to the vitreous by a foreign object (for
example, in patients with siderosis), or when it accumulates in
the RPE in aceruloplasminemia due to mutations in the Fe ex-
porter ceruloplasmin (2, 3). RPE cells are also a target of reti-
nopathy associated with β-thalassemia, an autosomal recessive
hemoglobinopathy requiring blood transfusions for survival (4).
Fe accumulates in RPE with age-related macular degeneration
(AMD) (5, 6).
RPE cells are unusual in that they are subjected to an age-
related accumulation of photoreactive vitamin A aldehyde-
derived compounds (7–11). This family of fluorophores, only
one of which is A2E, has bisretinoid structures and constitutes
the lipofuscin of RPE. The structure common to all of these
fluorophores is a conjugated system of double bonds along each
of two side arms that terminate in β-ionone rings. The polyene
structures on the long arms of the fluorophore generate absor-
bances in the visible range of the spectrum (12) and allow for
both electron and energy transfer. The molecular and cell
damage mediated by these compounds is attributable, at least
in some measure, to their propensity to photogenerate reac-
tive oxygen species and to photodegrade into aldehyde- and
dicarbonyl-bearing fragments (13, 14). Some of these photo-
degradation products are the dicarbonyls methylglyoxal (MG)
and glyoxal (GO) (13, 14) that modify proteins and are known to
populate subretinal drusen (15, 16). This bisretinoid photo-
degradative process is responsible for the lower bisretinoid levels
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measured in albino versus black mice and in light- versus dark-
reared mice (17) and may explain why early and intermediate
AMD are associated with lower fundus autofluorescence intensity
[measured as quantitative fundus autofluorescence (qAF)] in
central retina (18). There is evidence that this photodegradative
process is also ongoing in human retina. For instance, photo-
oxidation and photodegradation can explain the RPE lipofuscin
fluorescence bleaching that occurs in nonhuman primates during
in vivo fluorescence imaging (19, 20). Similar fluorescence
bleaching probably also accounts for the hyperautofluorescent
lines coursing parallel to retinal blood vessels that are sometimes
visible in fundus AF images when the position of vessels relative
to RPE has changed after surgical repair of retinal detachment
(21, 22). In the latter case, it is possible that under the shadow of
a blood vessel, lipofuscin photobleaching is reduced and thus a
vessel imprint of more intense autofluorescence is revealed upon
retinal translocation.
Our initial observation that the FDA-approved Fe chelator
deferiprone (DFP) when delivered to mice, altered bisretinoid
levels in retina, led us to consider whether the oxidative pro-
cesses enabled by intracellular Fe accentuates bisretinoid oxi-
dation and degradation. Thus, we embarked on a plan to
examine the combined effects of Fe and bisretinoid on oxidative
insult to RPE and photoreceptor cells.
Results
Quantitation of Bisretinoids in DFP-Treated Mice by High-Performance
Liquid Chromatography. The Fe chelator DFP is moderately lipo-
philic, cell permeable, and has been shown in mice to reduce
intracellular Fe burden in retina without evidence of retinal
toxicity (23–26). We delivered DFP to wild-type agouti 129/SvJ
mice and to albino Abca4−/− mice from age 2–6 mo. The Abca4
null mutant mouse is well known to accumulate bisretinoid flu-
orophores such as A2E and A2-GPE at elevated rates (27–30). In
the DFP-treated albino Abca4−/− mice, A2E/iso-A2E were pre-
sent in amounts that were twofold higher (P < 0.05) than in
control untreated mice (difference as percentage of control)
(Fig. 1). A2E levels in the DFP-treated agouti wild-type mice
were 49% higher than in untreated mice (P < 0.05). This treat-
ment effect can be explained as a DFP-mediated reduction in
the degradative loss of bisretinoid. Since photodegradation of
bisretinoid is more pronounced in the albino eye (17), high-
performance liquid chromatography (HPLC)-quantified bisreti-
noid was not appreciably different in albino Abca4−/− versus
agouti Abca4+/+ mice (Fig. 1 B and C).
Measuring Fundus Autofluorescence in DFP-Treated Mice by qAF. We
also measured bisretinoid noninvasively using a previously pub-
lished in vivo qAF approach (31, 32). Analysis revealed 26%
higher levels of fundus autofluorescence in albino Abca4−/− mice
treated with DFP from age 2–4 mo (P > 0.05) and 56% increased
qAF in the mice treated from 2 to 6 mo of age (P < 0.05) (Fig. 2).
The higher qAF in DFP-treated compared with untreated mice
is indicative of reduced bisretinoid loss due to oxidation. The
difference between DFP-treated and control mice when mea-
sured by qAF is less than when measured by HPLC. We attribute
this to the greater baseline short-wavelength fundus autofluorescence
(SW-AF) signal recorded in albino mice due to the more pro-
nounced intraocular light.
Measuring Retinal Fe Levels Through Transferrin Receptor qPCR.
When cells need more Fe, transferrin receptor mRNA is stabi-
lized, leading to more Fe uptake (33). Transferrin receptor
Fig. 1. The bisretinoids A2E, A2-GPE, and A2-DHP-PE in mice treated with
the Fe chelator DFP. Oral DFP was administered from age 2 to 6 mo. (A)
Representative reverse phase HPLC chromatographs illustrating the de-
tection of all trans-retinal (atRAL), A2E (Rt 37.6 m), iso-A2E (Rt 39.4 m),
A2-GPE (Rt 39.8 m), and A2-DHP-PE (Rt 45.3 m). (Insets at Right) UV-visible
spectra of chromatographic peaks corresponding to A2E (all-trans-A2E),
iso-A2E (C13/14 cis-A2E), A2-GPE, and A2-DHP-PE. (B and C) Chro-
matographic quantitation of bisretinoids in albino Abca4−/− and agouti
129 wild-type mice. A2E (the sum of all-trans-A2E and iso-A2E) and
A2-DHP-PE were quantified by HPLC. A2-GPE was quantified by UPLC.
Values are means ± SEM; four eyes (two mice) or six eyes (three mice) were
pooled for each sample of DFP-treated or control albino Abca4−/− mice,
and eight eyes (four mice) were pooled for agouti 129Sv mice. P values
were determined by one-way ANOVA and Sidak’s multiple comparison
test. Rt, retention time.
Fig. 2. Quantitative fundus autofluorescence (qAF) (488 nm) in Abca4−/− albino mice aged 4 and 6 mo. Mice were treated with DFP beginning at 2 mo of age.
(A) qAF increases in DFP-treated mice. Values are means ± SEM, eight or nine mice per group. P value was determined by one-way ANOVA and Sidak’s
multiple comparison test. (B) Short-wavelength fundus autofluorescence images acquired for qAF analysis. Note that in the two images, the fundus appears
to present with similar gray levels; however, the internal reference at the Top of the image of the DFP-treated mouse is darker, indicating higher fundus AF
(qAF) levels.
4964 | www.pnas.org/cgi/doi/10.1073/pnas.1722601115 Ueda et al.
mRNA levels reflect intracellular Fe concentrations (23, 34),
since in cells needing more Fe, transferrin receptor mRNA is
stabilized. In Abca4−/− mice receiving DFP in drinking water
from age 2 mo, transferrin receptor mRNA levels, quantified in
neural retina by qRT-PCR (35) were 1.73-fold greater than
controls (P < 0.05) at 4 mo of age, while the fold change in RPE/
choroid/sclera was 1.66 (P < 0.05) (Fig. 3).
Outer Nuclear Layer Thickness. In albino Abca4−/− mice, the
accelerated formation of bisretinoid leads to reduced photore-
ceptor cell viability that is detected at age 8 mo by measuring the
thickness of the outer nuclear layer (ONL) (31, 36). In the DFP-
treated mice, thinning of the ONL was less pronounced (Fig. 4).
Interobserver agreement was calculated according to Bland and
Altman (37). The mean difference between two observers (bias)
was 0.05 μm and the 95% limits of agreement was −1.8–1.7 μm.
The ONL area, determined using the sum of ONL thicknesses in
superior and inferior retina (0.2–2 mm), was increased by 25% (P <
0.001, unpaired two-tailed t test) in superior hemiretina of mice
receiving oral DFP and 17% (P < 0.001) in inferior hemiretina
compared with the control mice.
Cp−/−; Heph−/− Mice. Cp and its homolog Heph are copper-
containing ferroxidase proteins that convert Fe2+ to Fe3+ so as to
enable cellular Fe export. Accordingly, deficiency in Heph and
Cp leads to elevated intracellular Fe in RPE (38). We found that
Cp−/−; Heph−/− mice also exhibited reduced bisretinoid mea-
sured as A2E/iso-A2E (Fig. 5). We interpret this finding as in-
dicative of increased A2E oxidation and degradation due to
elevated Fe.
In Vitro Mechanistic Experiments. The higher levels of bisretinoid
and qAF in DFP-treated mice (Figs. 1 and 2) are consistent with
a mechanism involving a reduction in oxidation-associated deg-
radation of bisretinoid in the presence of Fe chelation. Support
for the latter mechanism was forthcoming in experiments
employing a human RPE cell line (ARPE-19) that had accu-
mulated A2E and was irradiated with 430 nm light (Fig. 6). Loss
of A2E due to oxidation and degradation was diminished in cells
pretreated with DFP before light exposure (Fig. 6A). Moreover,
the corresponding loss of cell viability that is associated with
these conditions was reduced with DFP pretreatment (Fig. 6B).
Since H2O2 in the presence of Fe
2+ (Fenton reaction) also
generates highly reactive hydroxyl radical (OH•), we tested light-
independent effects of these Fenton chemistry reactants on A2E.
Exposure of A2E to FeSO4 and H2O2 degraded A2E with con-
comitant release of MG and GO that were detected by trapping
with 2,4-dinitrophenylhydrazine (DNPH) (Fig. 7 A and B) (Fig.
S1). Moreover, DFP reduced the production of MG and GO by
Fenton chemistry, suppressed the degradative loss of A2E and
reduced the formation of oxidized forms of A2E (Fig. 7 B
and C).
Discussion
Here in Abca4−/− mice treated with the Fe chelator DFP, we
observed an increase in HPLC quantified bisretinoid and higher
fundus AF intensity measured as qAF. Conversely, elevated Fe
in RPE of Cp−/−; Heph−/− mice (39) resulted in decreased bis-
retinoids. These findings indicate that Fe can promote the
oxidation-based degradation of bisretinoid. This interpretation is
further supported by ancillary in vitro data showing that DFP
protected against degradative loss of A2E in the presence of
light, while Fe and H2O2 promoted the degradation of A2E. The
DFP-associated protection against ONL thinning also indicates
that the process of Fe-promoted bisretinoid oxidation-associated
degradation contributes to photoreceptor cell loss in ABCA4-
related disease. These findings are consistent with our previous
observation that the antioxidant activity of vitamin E conserved
levels of RPE bisretinoid by suppressing photooxidation (17), the
Fig. 3. Effect of DFP on ocular transferrin receptor expression in Abca4−/−
albino mice. Transferrin receptor mRNA is increased in neural retina (age
4 mo) and RPE/choroid/sclera (age 4 and 6 mo) in DFP-treated mice begin-
ning at age 2 mo. Each value is the mean of four eyes analyzed from two
mice. P values were derived by one-way ANOVA and Sidak’s multiple com-
parison test.
Fig. 4. Outer nuclear layer (ONL) thickness in 8-mo-old Abca4−/− albino mice. (A) ONL (mean ± SEM) in DFP-treated (n, 14) and control (n, 11) mice are plotted
as distance from optic nerve head (ONH). (B) ONL areas calculated from ONL thickness measurements acquired 0.2–2.0 mm from the ONH in superior and
inferior hemiretinae. P values were determined by one-way ANOVA and Sidak’s multiple comparison test.











higher levels of RPE bisretinoid being evidenced by quantitative
HPLC and qAF. Measurement of outer nuclear layer thickness also
revealed photoreceptor cell protection in the vitamin E-treated
Abca4−/− mice. Since photodegradation of bisretinoid is more
pronounced in albino versus pigmented mice, HPLC-quantified
bisretinoid is more abundant in pigmented mice (17) (Fig. 1).
We have previously demonstrated that lipofuscin bisretinoids
can be consumed by the processes of photooxidation and pho-
todegradation even in ambient lighting (17). Bisretinoids are
prone to oxidation because of their conjugated systems of double
bonds (e.g., C-C = C-C = C). The oxidation of bisretinoids can
proceed by multiple independent mechanisms (10, 40, 41). For
instance, using A2E as a model it has been shown that bisreti-
noids are visible light photosensitizers that generate singlet ox-
ygen by energy transfer, and superoxide anion by donation of an
electron to ground state molecular O2 (10, 40–42). As with some
other photosensitizers (43), A2E can also serve as the substrate
for reaction (oxidation) with singlet oxygen and radical oxygen
species at double bonds (10, 44). Thus, the side arms of A2E are
subsequently oxidized by a molecular singlet oxygen-mediated
pathway that adds two oxygen atoms to form a cyclic peroxide
(m/z 624) (10, 13, 42, 45). Alternatively addition of one oxygen
atom can also occur so as to form epoxide and furanoid moieties
(44, 46). Here the produced superoxide anion can generate
H2O2 by dismutation [spontaneously or superoxide dismutase
(SOD)-catalyzed] followed by the highly reactive hydroxyl radi-
cal (OH•) that is generated from H2O2 with Fe as catalyst. The
OH• radical is a powerful oxidant because of its unpaired elec-
tron (47, 48). Accordingly, OH• can readily break carbon double
bonds, especially the conjugated double bonds like those that
form the side arms of bisretinoids. This reactivity is significant,
given the present findings indicating that in the absence of light,
the OH• radical can also oxidize A2E.
Oxidative degradation of bisretinoids such as A2E and all-
trans-retinal dimer, releases a mixture of aldehyde- and dicarbonyl-
bearing fragments (MG and GO) that elicit cellular damage.
Since it has been reported that reaction of MG with L-arginine
can be catalyzed by Fe (particularly Fe2+) (49), Fe may also
promote the modification of proteins by bisretinoid photofrag-
ments. Electron donors produced by light exposure such as su-
peroxide anion (O2
−) or cellular reductants such as glutathione
(GSH) or ascorbate, both of which are abundant in the retina,
can recycle Fe3+ to Fe2+, enabling Fe to act catalytically even
when Fe availability is low.
The retina is subject to photochemical damage that is readily
demonstrable by exposure to light for prolonged periods or at
heightened intensities (50, 51). Efforts to understand the mo-
lecular mechanisms of light damage have identified both Fe (52)
and bisretinoids (53) as participants. In the latter case, we found
that light damage-associated ONL thinning and dropout of RPE
nuclei were more pronounced in Abca4−/− mice having elevated
levels of RPE bisretinoid than in age-matched wild-type mice.
The ONL thinning was also greater in 5-mo-old versus 2-mo-old
mice. In Rpe65rd12 mice bisretinoids are not detected chro-
matographically and light damage was not observed (53). Sys-
temic administration of the Fe chelator and antioxidant lipoic
acid (alpha-lipoic acid) or DFP protects against light-induced
photoreceptor degeneration in the mouse retina (34, 54). DFP,
when administered orally to mice (1 mg/mL, 5 mg/d) has been
shown to protect against retinal degeneration when the latter is
induced by RPE Fe accumulation in Cp/Heph double KO (DKO)
mice (55), by sodium iodate-mediated oxidative damage to RPE
cells or by the rd6 mutation (24).
Fe and bisretinoids may also have links to AMD. The benefits
afforded to patients with AMD by antioxidant intake indicate
that oxidative mechanisms are an important factor contributing
to AMD pathogenesis (56, 57). It is thus significant that Fe and
bisretinoid initiate separate, but perhaps overlapping toxic oxi-
dative processes (49, 58, 59). Perls’ staining revealed that Fe
levels were increased in AMD-affected maculas compared with
healthy age-matched maculas (5) particularly in the RPE and
Bruch’s membrane of early AMD, geographic atrophy, and pa-
tients with exudative AMD. Examination of the postmortem
macula of a 72-y-old white male with geographic atrophy
revealed Fe overload in the RPE and photoreceptor cell layers
along with ferritin and ferroportin in the photoreceptor cells and
internal limiting membrane. Conversely, healthy maculas were
only weakly labeled with anti-ferritin and anti-ferroportin anti-
body (60). Transferrin is also up-regulated in AMD (61). Pro-
teins modified by dicarbonyls are detected in sub-RPE drusen
(15, 16) and these dicarbonyls are the same as those released by
photodegradation of bisretinoids such as A2E and all-trans-ret-
inal dimer. These findings indicate a possible link between
photodegradation of RPE lipofuscin and sub-RPE changes that
confer risk of AMD. Evidence that bisretinoid lipofuscin and Fe
can initiate damaging light-mediated mechanisms (described
above) is supported by epidemiological studies pointing to a
relationship between AMD risk and sunlight exposure (62–69).
Fig. 5. UPLC quantitation of A2E and iso-A2E in mice deficient in cerulo-
plasmin (Cp) and hephaestin (Heph) (Cp−/−; Heph−/−) and Cp+/−; Heph−/− mice.
(A) Detection of A2E and iso-A2E in Cp+/−; Heph−/− and Cp−/−; Heph−/− mice.
(Insets at Top) UV-visible spectra of chromatographic peaks corresponding to
A2E (all-trans-A2E) and iso-A2E (C13/14 cis-A2E). (B) Picomoles per eye were
calculated using calibration curves constructed from authentic standards. ND,
not detected. Values based on single samples, four to eight eyes per sample.
Fig. 6. Effects of DFP in the presence of bisretinoid photooxidation: cellular
assays. ARPE-19 cells that have accumulated A2E were treated with DFP (30,
60, and 100 μM, 30 min) and then illuminated at 430 nm. (A) The Fe chelator
DFP reduces photooxidative loss of A2E in ARPE-19 cells (HPLC analysis). (B)
The reduced cell viability associated with A2E photooxidation was attenu-
ated by pretreatment with the Fe chelator DFP. P values were determined by
one-way ANOVA and Tukey’s multiple comparison test.
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These findings point to opportunities for drug repurposing and
combination therapies. For instance, Fe chelation alone or in
combination with inhibitors of bisretinoid formation (70) could
serve as a unique therapy for recessive Stargardt disease (STGD1),
a bisretinoid-related disease, and possibly AMD. Conversely,
drugs that suppress the synthesis and toxic activities of bisreti-
noid could be beneficial for Fe-related conditions such as
siderosis retinopathy.
Methods
Mouse Models. Albino Abca4−/−, agouti 129S1/SvImJ mice and mice deficient
in ceruloplasmin and hephaestin (Cp−/−; Heph−/−) (38) were studied. Mice
received DFP (Ferriprox) (Barr Pharma, pharmaceutical grade) in drinking
water (1 mg/mL) from age 2 mo to age 4 or 6 mo. The intake of DFP was ∼3–
5 mg per day. Animal protocols were approved by the Institutional Animal
Care and Use Committee of Columbia University. Details are provided in
Supporting Information.
Quantitative HPLC and Ultra Performance Liquid Chromatography. Mouse
eyecups (4–8 eyes per sample as indicated) were homogenized, extracted
in chloroform/methanol (2:1), and analyzed for bisretinoid by reversed-
phase HPLC (A2E, iso-A2E) using an Alliance System (Waters Corp.) or
Waters Acquity Ultra Performance Liquid Chromatography (UPLC)-MS
System (A2E and iso-A2E in X-bridge, A2-GPE in phenyl) (Waters) as de-
scribed (17, 29). Molar quantities per eye were calculated by comparison
with synthesized standards. The pyridinium bisretinoid A2E and its cis
isomer, iso-A2E, were measured separately and summed (A2E/iso-A2E). To
detect DNP-derivatized dicarbonyl, incubated samples were extracted and
analyzed by UPLC-MS (71).
qAF. Images were acquired and analyzed as previously described (31).
Cell and Cell-Free Assays. ARPE-19 cells that had accumulated A2E (71) were
treated with the Fe chelator DFP (30–100 μM) and then irradiated (430 ±
30 nm) for 30 min. A2E was then extracted and quantified by HPLC (17).
Cytotoxicity was measured by the MTT (4,5-dimethylthiazol-2-yl)-2,5-diphe-
nyltetrazolium bromide) colorimetric assay (Roche Diagnostics Corporation)
(72). Synthesized A2E (9) (50 μM in distilled water with 0.5% DMSO) was
incubated with FeSO4 (200 μM), H2O2 (500 μM), and DFP (600 μM) for 3 h at
37 °C and peak areas were quantified by UPLC (73).
Measurement of ONL Thickness. Sagittal sections traversing the optic nerve
head were analyzed and the ONL area was calculated (36).
qRT-PCR for Transferrin Receptor Expression. Neural retina was separated
fromRPE/choroid/sclera, total RNAwas isolated usingQiagenRNeasy PlusMicro
kit (Qiagen), and reverse transcription was performed (Reverse Transcription
kit; Thermo Fisher Scientific) (23, 34). Real-time PCR was performed with Ap-
plied Biosystems 7900HT. Probes and primers were as follows: transferrin re-
ceptor, Mm00441941_m1; 18s rRNA internal control, Hs99999901_s1.
ACKNOWLEDGMENTS. This work was supported by grants from the National
Eye Institute (EY012951 and P30EY019007) and Research to Prevent
Blindness to the Department of Ophthalmology, Columbia University and
the University of Pennsylvania, the Paul and Evanina Bell Mackall Founda-
tion Trust, and the F. M. Kirby Foundation.
1. Halliwell B, Gutteridge JMC (2015) Free Radicals in Biology and Medicine (Oxford Univ
Press, Oxford), 5th Ed.
2. Dunaief JL, et al. (2005) Macular degeneration in a patient with aceruloplasminemia,
a disease associated with retinal iron overload. Ophthalmology 112:1062–1065.
3. Wolkow N, et al. (2011) Aceruloplasminemia: Retinal histopathologic manifestations
and iron-mediated melanosome degradation. Arch Ophthalmol 129:1466–1474.
4. Bhoiwala DL, Dunaief JL (2016) Retinal abnormalities in β-thalassemia major. Surv
Ophthalmol 61:33–50.
5. Hahn P, Milam AH, Dunaief JL (2003) Maculas affected by age-related macular de-
generation contain increased chelatable iron in the retinal pigment epithelium and
Bruch’s membrane. Arch Ophthalmol 121:1099–1105.
6. Biesemeier A, Yoeruek E, Eibl O, Schraermeyer U (2015) Iron accumulation in Bruch’s
membrane and melanosomes of donor eyes with age-related macular degeneration.
Exp Eye Res 137:39–49.
7. Eldred GE, Katz ML (1988) Fluorophores of the human retinal pigment epithelium:
Separation and spectral characterization. Exp Eye Res 47:71–86.
8. Dorey CK, Wu G, Ebenstein D, Garsd A, Weiter JJ (1989) Cell loss in the aging retina.
Relationship to lipofuscin accumulation and macular degeneration. Invest Ophthalmol
Vis Sci 30:1691–1699.
9. Parish CA, Hashimoto M, Nakanishi K, Dillon J, Sparrow J (1998) Isolation and one-step
preparation of A2E and iso-A2E, fluorophores from human retinal pigment epithe-
lium. Proc Natl Acad Sci USA 95:14609–14613.
10. Ben-Shabat S, et al. (2002) Formation of a nonaoxirane from A2E, a lipofuscin fluo-
rophore related to macular degeneration, and evidence of singlet oxygen in-
volvement. Angew Chem Int Ed Engl 41:814–817.
11. Liu J, Itagaki Y, Ben-Shabat S, Nakanishi K, Sparrow JR (2000) The biosynthesis of A2E,
a fluorophore of aging retina, involves the formation of the precursor, A2-PE, in the
photoreceptor outer segment membrane. J Biol Chem 275:29354–29360.
12. Kim SR, Jang YP, Sparrow JR (2010) Photooxidation of RPE lipofuscin bisretinoids
enhances fluorescence intensity. Vision Res 50:729–736.
13. Wu Y, Yanase E, Feng X, Siegel MM, Sparrow JR (2010) Structural characterization of
bisretinoid A2E photocleavage products and implications for age-related macular
degeneration. Proc Natl Acad Sci USA 107:7275–7280.
14. Yoon KD, Yamamoto K, Ueda K, Zhou J, Sparrow JR (2012) A novel source of
methylglyoxal and glyoxal in retina: Implications for age-related macular de-
generation. PLoS One 7:e41309.
15. Handa JT, et al. (1999) Increase in the advanced glycation end product pentosidine in
Bruch’s membrane with age. Invest Ophthalmol Vis Sci 40:775–779.
16. Crabb JW, et al. (2002) Drusen proteome analysis: An approach to the etiology of age-
related macular degeneration. Proc Natl Acad Sci USA 99:14682–14687.
17. Ueda K, Zhao J, Kim HJ, Sparrow JR (2016) Photodegradation of retinal bisretinoids in
mouse models and implications for macular degeneration. Proc Natl Acad Sci USA
113:6904–6909.
18. GliemM, et al. (2016) Quantitative fundus autofluorescence in early and intermediate
age-related macular degeneration. JAMA Ophthalmol 134:817–824.
Fig. 7. Fenton reaction products oxidize and degrade A2E. Detection of dicarbonyl compounds and oxidized A2E species. (A) UPLC-MS detection of authentic
glyoxal-DNP (GO-DNP; Rt 3.5 m) (red) and two isomers of methylglyoxal-DNP (MG-DNP; Rt 2.1, 2.5 m) (black) and DNP-derivatized products generated when A2E
was incubated with FeSO4 and H2O2. MS-selected ion monitoring chromatograms at m/z 237 and 251 [M-H]
−. (B) Quantitation of dicarbonyls in ion monitoring
chromatograms. Values are means ± SEM, two independent experiments; P values were determined by one-way ANOVA and Sidak’s multiple comparison test.
(C) HPLC quantitation of the consumption of A2E (Left) and formation of oxidized A2E species (Right) in the presence of FeSO4 and H2O2. Values are means ± SEM
of two independent experiments; P values were determined by one-way ANOVA and Tukey’s multiple comparison test. Rt, retention time.











19. Morgan JI, Dubra A, Wolfe R, Merigan WH, Williams DR (2009) In vivo auto-
fluorescence imaging of the human and macaque retinal pigment epithelial cell
mosaic. Invest Ophthalmol Vis Sci 50:1350–1359.
20. Morgan JI, et al. (2008) Light-induced retinal changes observed with high-resolution
autofluorescence imaging of the retinal pigment epithelium. Invest Ophthalmol Vis
Sci 49:3715–3729.
21. Pandya VB, Ho IV, Hunyor AP (2012) Does unintentional macular translocation after
retinal detachment repair influence visual outcome? Clin Experiment Ophthalmol 40:
88–92.
22. Shiragami C, et al. (2010) Unintentional displacement of the retina after standard
vitrectomy for rhegmatogenous retinal detachment. Ophthalmology 117:86–92.e1.
23. Hadziahmetovic M, et al. (2011) The oral iron chelator deferiprone protects against
iron overload-induced retinal degeneration. Invest Ophthalmol Vis Sci 52:959–968.
24. Hadziahmetovic M, et al. (2012) The oral iron chelator deferiprone protects against
retinal degeneration induced through diverse mechanisms. Transl Vis Sci Technol 1:7.
25. Song D, et al. (2014) The oral iron chelator deferiprone protects against systemic iron
overload-induced retinal degeneration in hepcidin knockout mice. Invest Ophthalmol
Vis Sci 55:4525–4532.
26. Song D, Dunaief JL (2013) Retinal iron homeostasis in health and disease. Front Aging
Neurosci 5:24.
27. Radu RA, et al. (2008) Accelerated accumulation of lipofuscin pigments in the RPE of a
mouse model for ABCA4-mediated retinal dystrophies following Vitamin A supple-
mentation. Invest Ophthalmol Vis Sci 49:3821–3829.
28. Weng J, et al. (1999) Insights into the function of Rim protein in photoreceptors and
etiology of Stargardt’s disease from the phenotype in abcr knockout mice. Cell 98:
13–23.
29. Yamamoto K, Yoon KD, Ueda K, Hashimoto M, Sparrow JR (2011) A novel bisretinoid
of retina is an adduct on glycerophosphoethanolamine. Invest Ophthalmol Vis Sci 52:
9084–9090.
30. Kim SR, et al. (2007) The all-trans-retinal dimer series of lipofuscin pigments in retinal
pigment epithelial cells in a recessive Stargardt disease model. Proc Natl Acad Sci USA
104:19273–19278.
31. Sparrow JR, et al. (2013) Quantitative fundus autofluorescence in mice: Correlation
with HPLC quantitation of RPE lipofuscin and measurement of retina outer nuclear
layer thickness. Invest Ophthalmol Vis Sci 54:2812–2820.
32. Flynn E, Ueda K, Auran E, Sullivan JM, Sparrow JR (2014) Fundus autofluorescence and
photoreceptor cell rosettes in mouse models. Invest Ophthalmol Vis Sci 55:5643–5652.
33. He X, et al. (2007) Iron homeostasis and toxicity in retinal degeneration. Prog Retin
Eye Res 26:649–673.
34. Hadziahmetovic M, et al. (2012) Microarray analysis of murine retinal light damage
reveals changes in iron regulatory, complement, and antioxidant genes in the neu-
rosensory retina and isolated RPE. Invest Ophthalmol Vis Sci 53:5231–5241.
35. Chen P, et al. (2001) A photic visual cycle of rhodopsin regeneration is dependent on
Rgr. Nat Genet 28:256–260.
36. Wu L, Nagasaki T, Sparrow JR (2010) Photoreceptor cell degeneration in Abcr (-/-) mice.
Adv Exp Med Biol 664:533–539.
37. Bland JM, Altman DG (1986) Statistical methods for assessing agreement between
two methods of clinical measurement. Lancet 1:307–310.
38. Hahn P, et al. (2004) Disruption of ceruloplasmin and hephaestin in mice causes ret-
inal iron overload and retinal degeneration with features of age-related macular
degeneration. Proc Natl Acad Sci USA 101:13850–13855.
39. Wolkow N, et al. (2012) Ferroxidase hephaestin’s cell-autonomous role in the retinal
pigment epithelium. Am J Pathol 180:1614–1624.
40. Pawlak A, et al. (2003) Comparison of the aerobic photoreactivity of A2E with its
precursor retinal. Photochem Photobiol 77:253–258.
41. Gaillard ER, et al. (2004) A mechanistic study of the photooxidation of A2E, a com-
ponent of human retinal lipofuscin. Exp Eye Res 79:313–319.
42. Sparrow JR, et al. (2002) Involvement of oxidative mechanisms in blue-light-induced
damage to A2E-laden RPE. Invest Ophthalmol Vis Sci 43:1222–1227.
43. Bonnett R, Martinez G (2001) Photobleaching of sensitisers used in photodynamic
therapy. Tetrahedron 57:9513–9547.
44. Jang YP, Matsuda H, Itagaki Y, Nakanishi K, Sparrow JR (2005) Characterization of
peroxy-A2E and furan-A2E photooxidation products and detection in human and
mouse retinal pigment epithelial cell lipofuscin. J Biol Chem 280:39732–39739.
45. Sparrow JR, et al. (2003) A2E-epoxides damage DNA in retinal pigment epithelial
cells. Vitamin E and other antioxidants inhibit A2E-epoxide formation. J Biol Chem
278:18207–18213.
46. Dillon J, Wang Z, Avalle LB, Gaillard ER (2004) The photochemical oxidation of A2E
results in the formation of a 5,8,5′,8′-bis-furanoid oxide. Exp Eye Res 79:537–542.
47. Stephenson NA, Bell AT (2007) Mechanistic insights into iron porphyrin-catalyzed
olefin epoxidation by hydrogen peroxide: Factors controlling activity and selectivity.
J Mol Catal A Chem 275:54–62.
48. Gelalcha FG, Bitterlich B, Anilkumar G, Tse MK, Beller M (2007) Iron-catalyzed
asymmetric epoxidation of aromatic alkenes using hydrogen peroxide. Angew Chem
Int Ed Engl 46:7293–7296.
49. Wittmann I, et al. (2001) Role of iron in the interaction of red blood cells with
methylglyoxal. Modification of L-arginine by methylglyoxal is catalyzed by iron redox
cycling. Chem Biol Interact 138:171–187.
50. Hunter JJ, et al. (2012) The susceptibility of the retina to photochemical damage from
visible light. Prog Retin Eye Res 31:28–42.
51. Organisciak DT, Vaughan DK (2010) Retinal light damage: Mechanisms and pro-
tection. Prog Retin Eye Res 29:113–134.
52. Chen L, et al. (2003) Increased expression of ceruloplasmin in the retina following
photic injury. Mol Vis 9:151–158.
53. Wu L, Ueda K, Nagasaki T, Sparrow JR (2014) Light damage in Abca4 and
Rpe65rd12 mice. Invest Ophthalmol Vis Sci 55:1910–1918.
54. Zhao L, et al. (2014) Systemic administration of the antioxidant/iron chelator α-lipoic
acid protects against light-induced photoreceptor degeneration in the mouse retina.
Invest Ophthalmol Vis Sci 55:5979–5988.
55. Greferath U, Guymer RH, Vessey KA, Brassington K, Fletcher EL (2016) Correlation of
histologic features with in vivo imaging of reticular pseudodrusen. Ophthalmology
123:1320–1331.
56. Fritsche LG, et al. (2013) Seven new loci associated with age-related macular de-
generation. Nat Genet 45:433–439, 439e1–2.
57. Handa JT (2012) How does the macula protect itself from oxidative stress? Mol
Aspects Med 33:418–435.
58. Zhou J, Gao X, Cai B, Sparrow JR (2006) Indirect antioxidant protection against
photooxidative processes initiated in retinal pigment epithelial cells by a lipofuscin
pigment. Rejuvenation Res 9:256–263.
59. Jang YP, Zhou J, Nakanishi K, Sparrow JR (2005) Anthocyanins protect against A2E
photooxidation and membrane permeabilization in retinal pigment epithelial cells.
Photochem Photobiol 81:529–536.
60. Dentchev T, Hahn P, Dunaief JL (2005) Strong labeling for iron and the iron-handling
proteins ferritin and ferroportin in the photoreceptor layer in age-related macular
degeneration. Arch Ophthalmol 123:1745–1746.
61. Chowers I, et al. (2006) The iron carrier transferrin is upregulated in retinas from
patients with age-related macular degeneration. Invest Ophthalmol Vis Sci 47:
2135–2140.
62. Cruickshanks KJ, Klein R, Klein BEK (1993) Sunlight and age-related macular de-
generation. The Beaver Dam Eye study. Arch Ophthalmol 111:514–518.
63. Tomany SC, Cruickshanks KJ, Klein R, Klein BEK, Knudtson MD (2004) Sunlight and the
10-year incidence of age-related maculopathy: The Beaver Dam Eye study. Arch
Ophthalmol 122:750–757.
64. Cruickshanks KJ, Klein R, Klein BEK, Nondahl DM (2001) Sunlight and the 5-year in-
cidence of early age-related maculopathy: The beaver dam eye study. Arch
Ophthalmol 119:246–250.
65. Klein BE, et al. (2014) Sunlight exposure, pigmentation, and incident age-related
macular degeneration. Invest Ophthalmol Vis Sci 55:5855–5861.
66. Huang EJ, et al. (2014) Prevalence and risk factors for age-related macular de-
generation in the elderly Chinese population in south-western Taiwan: The Puzih eye
study. Eye (Lond) 28:705–714.
67. Schick T, et al. (2016) History of sunlight exposure is a risk factor for age-related
macular degeneration. Retina 36:787–790.
68. Fletcher AE, et al. (2008) Sunlight exposure, antioxidants, and age-related macular
degeneration. Arch Ophthalmol 126:1396–1403.
69. Sui GY, et al. (2013) Is sunlight exposure a risk factor for age-related macular de-
generation? A systematic review and meta-analysis. Br J Ophthalmol 97:389–394.
70. Sparrow JR (2016) Vitamin A-aldehyde adducts: AMD risk and targeted therapeutics.
Proc Natl Acad Sci USA 113:4564–4569.
71. Zhou J, Ueda K, Zhao J, Sparrow JR (2015) Correlations between photodegradation of
bisretinoid constituents of retina and dicarbonyl-adduct deposition. J Biol Chem 290:
27215–27227.
72. Zhao J, Kim HJ, Sparrow JR (2017) Multimodal fundus imaging of sodium iodate-
treated mice informs RPE susceptibility and origins of increased fundus auto-
fluorescence. Invest Ophthalmol Vis Sci 58:2152–2159.
73. Sparrow JR, et al. (2012) The bisretinoids of retinal pigment epithelium. Prog Retin
Eye Res 31:121–135.
4968 | www.pnas.org/cgi/doi/10.1073/pnas.1722601115 Ueda et al.
